Patient preference study of once-monthly ibandronate versus once-weekly alendronate

被引：0
|
作者：
Emkey, R
Binkley, N
Seidman, L
Rosen, C
机构：
[1] Reading Hosp, Reading, PA USA
[2] Univ Wisconsin, Madison, WI 53706 USA
[3] Philadelphia Womens Res, Philadelphia, PA USA
[4] St Joseph Hosp, Bangor, ME 04401 USA
来源：
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY | 2005年 / 12卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
引用
收藏
页码：797 / 797
页数：1
相关论文
共 50 条
  • [41] Once-monthly ibandronate for postmenopausal osteoporosis: Review of a new dosing regimen
    Pyon, Eunice Y.
    CLINICAL THERAPEUTICS, 2006, 28 (04) : 475 - 490
  • [42] Once-Monthly Oral Ibandronate in Postmenopausal Osteoporosis: Translation and Updated Review
    Rossini, Maurizio
    Viapiana, Ombretta
    Gatti, Davide
    Adami, Silvano
    CLINICAL THERAPEUTICS, 2009, 31 (07) : 1497 - 1510
  • [43] Once-monthly ibandronate: Meeting patients' needs with efficacy, safety and tolerability
    Stone, M.
    OSTEOPOROSIS INTERNATIONAL, 2006, 17 : S357 - S358
  • [44] Effectiveness of once-monthly oral ibandronate treatment in adolescents with osteogenesis imperfecta
    Awadalla, Shokery S.
    HORMONE RESEARCH, 2009, 72 : 76 - 77
  • [45] Preference study of alendronate 70 mg once weekly and alendronate 10 mg once daily in postmenopausal women with osteoporosis
    Palmisano, J
    Lewiecki, EM
    Rosen, C
    Bockman, RS
    Vanaman, LK
    Smith, ME
    Wang, L
    Thompson, D
    Yates, J
    OSTEOPOROSIS INTERNATIONAL, 2002, 13 : S43 - S44
  • [46] Preference study of alendronate 70 mg once weekly and alendronate 10 mg once daily in postmenopausal women with osteoporosis
    Palmisano, J
    Melton, M
    Lewiecki, EM
    Rosen, R
    Bockman, RS
    Dinh, AC
    Smith, ME
    Wang, L
    Keene, W
    OSTEOPOROSIS INTERNATIONAL, 2002, 13 : S36 - S36
  • [47] Once weekly alendronate
    Sambrook, P
    DRUGS OF TODAY, 2003, 39 (05) : 339 - 346
  • [48] Response to therapy with once-weekly alendronate 70 mg compared to once-weekly risedronate 35 mg in the treatment of postmenopausal osteoporosis
    Sebba, AI
    Bonnick, SL
    Kagan, R
    Thompson, DE
    Skalky, CS
    Chen, EL
    de Papp, AE
    CURRENT MEDICAL RESEARCH AND OPINION, 2004, 20 (12) : 2031 - 2041
  • [49] Treatment with once-weekly alendronate oral jelly compared with once-weekly alendronate oral tablet for Japanese patients with primary osteoporosis: An open-label, prospective, observational study
    Okimoto, Nobukazu
    Uemura, Yukari
    Yoshioka, Toru
    Arita, Shinobu
    Tsurukami, Hiroshi
    Otomo, Hajime
    Nishida, Satoshi
    Ogawa, Takayuki
    Hirao, Ken
    Ikeda, Satoshi
    Matsumoto, Hidehiro
    Toten, Yoriko
    Katae, Yuji
    Okazaki, Yuichi
    Nakagawa, Tsuyoshi
    Sakai, Akinori
    HEALTH SCIENCE REPORTS, 2019, 2 (01)
  • [50] Safety of once-weekly alendronate 70 mg in periodontal disease
    Van Dyke, T
    Ryder, M
    Cordero, R
    Gallagher, A
    Griffiths, G
    Offenbacher, S
    Cizza, G
    Kimberlin, M
    Lombardi, A
    Meng, L
    Shih, W
    JOURNAL OF RHEUMATOLOGY, 2001, 28 : 26 - 26
12345